Posted by Sean Solarzano on Jan 20th, 2025
Mustang Bio, Inc. made a significant disclosure on January 14, 2025, announcing the implementation of a 1-for-50 reverse stock split of its issued and outstanding common stock. The company, a clinical-stage biopharmaceutical organization...
More of this article »